"10.1371_journal.pone.0092153","plos one","2014-03-25T00:00:00Z","Danuta M Skowronski; Naveed Z Janjua; Gaston De Serres; Suzana Sabaiduc; Alireza Eshaghi; James A Dickinson; Kevin Fonseca; Anne-Luise Winter; Jonathan B Gubbay; Mel Krajden; Martin Petric; Hugues Charest; Nathalie Bastien; Trijntje L Kwindt; Salaheddin M Mahmud; Paul Van Caeseele; Yan Li","Communicable Disease Prevention and Control Service, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; Clinical Prevention Services, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada; Department of Biological and Occupational Risks, Institut National de Santé Publique du Québec, Québec (Québec), Canada; Department of Social and Preventive Medicine, Laval University, Québec (Québec), Canada; Department of Molecular Research, Public Health Ontario, Toronto, Ontario, Canada; Family Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Department of Virology, Provincial Laboratory of Public Health, Calgary, Alberta, Canada; Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada; Communicable Disease Prevention and Control, Public Health Ontario, Toronto, Ontario, Canada; Department of Microbiology, Public Health Ontario, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada; Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada; Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada; Département De Microbiologie, Infectiologie et Immunologie, Faculté de médecine, Université de Montréal, Montréal, Québec, Canada; Influenza and Respiratory Virus Section, National Microbiology Laboratory, Winnipeg, Manitoba, Canada; Community Health Sciences and Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada; Cadham Provincial Laboratory, Manitoba Health, Winnipeg, Manitoba, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada","Conceived and designed the experiments: DMS GDS JAD MP. Performed the experiments: SS AE KF JBG HC NB PVC MK MP YL. Analyzed the data: NZJ DMS GDS SS AE KF JBG HC NB PVC MK MP YL. Wrote the paper: DMS NZJ GDS SS AE JAD KF ALW JBG MK MP HC NB TLK SMM PVC YL. Data collection: DMS NZJ GDS JAD ALW SMM TLK. Literature search: TLK.","Within 36 months of manuscript submission, GDS received research grants from GlaxoSmithKline (GSK) and Sanofi Pasteur for unrelated vaccine studies and travel fee reimbursement to attend an ad hoc GSK Advisory Board, without honorarium. JBG has received research grants from GSK and Hoffmann-LaRoche for antiviral resistance studies. MK has received research grants from Roche, Merck, Gen-Probe and Siemens. SMM has received research grants from GSK, Sanofi Pasteur and Pfizer. SMM is a Canada Research Chair in Pharmaco-epidemiology and Vaccine Evaluation; and the Great-West Life, London Life and Canada Life Junior Investigator of the Canadian Cancer Society [grant # 2011-700644]. SS and TLK are funded by the Canadian Institutes of Health Research Grant (TPA-90193). The other authors declare that they have no competing interests to report. This does not alter adherence to all PLOS policies on sharing data and materials.","2014","03","Danuta M Skowronski","DMS",17,FALSE,4,10,13,17,TRUE,TRUE,FALSE,0,NA,FALSE
